INO.com by TIFIN
Sign Up Log In
Welcome back!
Magnifi
Magnifi
  • Stocks & ETFs

    Pulse

    • Stock Market Snapshot

    World Indices

    • Americas
    • Asia/Pacific
    • Europe
    • Middle East/Africa

    U.S. Indices

    • Dow Jones Industrial Average
    • S&P 500

    Exchange Traded Funds (ETFs)

    • ETF Quote Board

    Market Action

    • Extreme Markets
    • Extreme Stock Winners
    • Extreme Stocks Losers
    • Extreme Stocks Under $5
    • Extreme Canadian Stocks
    • Extreme NASDAQ Stocks
    • Extreme NYSE Stocks
    • Recent Splits

    Free Tools & Analysis

    • Top Stocks
    • Top Penny Stocks
    • Top Tech Stocks
    • Top ETFs
    • Stock of the Week
    • Trend Analysis Report
  • Futures

    Pulse

    • Futures Market Snapshot

    By Category

    • Cryptocurrencies
    • Currencies
    • Energy
    • Food & Fiber
    • Grains & Oilseeds
    • Indexes
    • Interest Rates
    • Livestock & Meats
    • Metals
    • Real Estate
    • Weather

    Market Action

    • Extreme Winners
    • Extreme Losers
    • Open Futures

    By Exchange

    • CBOT Chicago Board of Trade
    • CME Chicago Mercantile Exchange
    • CLRP ClearPort
    • ICE Intercontinental Exchange
    • KCBT Kansas City Board of Trade
    • MGEX Minneapolis Grain Exchange
    • NYMEX New York Mercantile Exchange
    • All Futures & Commodity Symbols

    Free Tools & Analysis

    • Market Commentary
    • Daily Market Breakdown
    • Trend Analysis Report
  • Options

    Free Resources & Tools

    • Top Options
    • Options Boot Camp
    • Power Stock Strategy

    MarketClub Options

    • Training & Blueprint
    • Trader Travis
  • Forex

    Realtime Foreign Exchange

    • Dollar Rates
    • Euro Rates
    • Spot Metals
    • Asian Currencies
    • European Currencies
    • World Currencies
    • Cryptocurrencies

    Free Tools & Analysis

    • Top Forex Pairs
  • Resources

    INO Portfolio

    • Fast View
    • Detailed View
    • Login or Create Portfolio

    Drift Trader

    • Learn More
    • Log In

    MarketClub

    • Join Now
    • Log In
    • Trade Triangle Signals
    • Free Trend Analysis

    MarketClub Options

    • Free Boot Camp
    • Power Stock Strategy
    • Top Optionable Stocks

    Free Tools & Analysis

    • Market Commentary
    • Daily Market Breakdown
    • Trend Analysis Report

    Help

    • Email Services
    • About INO
    • Advertising
    • Contact Us
  • AI Investing
  • Blog

HealthEquity - Undervalued And Underappreciated Buy

Posted on September 29, 2020 by Noah Kiedrowski

HealthEquity (HQY) is an undervalued and underappreciated stock that is a buy at the sub $50 level. The stock is hovering just above its COVID-19 lows despite the epic market rally. HealthEquity (HQY) has fallen from its 52-week highs of $89 to a low of $35 or 60% during the COVID-19 market meltdown. The recent sell-off in equities has resulted in a 20% dive moving from $61 to $48. This sell-off presents a great opportunity for this healthcare cost containment company.

Considering HealthEquity’s unique position as being distinctly disassociated from drug pricing issues, rising insurance costs, or the pharmaceutical supply chain, this sell-off is a great opportunity for an entry point. HealthEquity is in a strong position and being offered at a heavy discount. For long-term investors, HealthEquity presents a compelling picture of growth with a large addressable market moving forward and further strengthened with its acquisition of WageWorks.

HealthEquity’s Q2 Earnings

HealthEquity announced its Q2 earnings with WageWorks being fully integrated into its financial numbers as the acquisition closed on August 30, 2019. Revenue for Q2 was $176 million, growing 103% compared to $86.6 million for the second quarter ended July 31, 2019. Revenue this quarter included: service revenue of $103.8 million, custodial revenue of $46.9 million, and interchange revenue of $25.3 million. HSAs now exceed 5.4 million, an increase of 29% year over year. Total Accounts as of July 31, 2020, reached 12.5 million, including 7.1 million CDBs. Total HSA Assets as of July 31, 2020, were $12.2 billion. Total HSA Assets included $9.0 billion of HSA cash and $3.2 billion of HSA investment assets (Figure 2).

HealthEquity
Figure 1 – High-level overview of the newly combined HealthEquity company branching out into all segments of consumer-directed benefits

HealthEquity
Figure 2 – HSA serves as a healthcare cost containment vehicle

COVID-19 Pandemic HSA Awareness

The COVID-19 pandemic will likely bring more attention to the Health Savings Account (HSA) space and may drive demand from more companies and consumers alike. The Health Savings account serves as a win-win for companies and consumers. This is an effective way to contain healthcare costs while allowing funds to accumulate for potential future medical expenses. This space has already been under a secular growth trend, and this pandemic may accelerate the growth of these accounts as awareness spreads.

Not A MarketClub Member Yet?

Getting started is easy! Test our tools with a 30-Day Trial.

Learn More

Conversely, in the short-term, HSA funds may be depleted at a faster rate by account holders. Contributions may fall due to the spike in unemployment, and employer matching contributions may be in jeopardy as liquidity comes into question for many companies that have transitioned into survival mode post-COVID-19. However, over the long term, this trend toward consumer-driven healthcare (i.e., channeling funds into HSAs) is here to stay.

Moat and Business Model

HealthEquity (HQY) has a unique business model that serves as an intermediary servicing the secular growth HSA space that’s largely independent of legislative actions, drug pricing, rising insurance costs while not playing any role in the pharmaceutical supply chain that spans from health insurers to end-user pharmacies. The company simply manages funds allocated for medical, dental, and vision expenses that are deducted on a pre-tax basis and deposited into a dedicated HSA account. The HSA space has grown in popularity as corporate adoption has allowed access to these plans in conjunction with consumer awareness. HealthEquity is an intermediary that connects health and wealth to consumers of healthcare.

Diversifying Revenue Streams

HealthEquity made a bold move to acquire WageWorks for approximately $2 billion in an all-cash deal. This acquisition has expanded HealthEquity’s moat in the HSA space while providing new revenue verticals in complementary product offerings. This move is already expanding HealthEquity’s total addressable market as Consumer-Directed Benefits (CDBs) via pre-tax spending accounts such as additional Health Savings Accounts (HSAs), health and dependent care Flexible Spending Accounts (FSAs), health reimbursement accounts (HRA), Commuter Benefit Services, wellness programs, COBRA and other employee benefits are absorbed into its product offerings. This acquisition provides access to a larger client base and access to health brokers that will help drive HealthEquity’s penetration over the long term. The combination of WageWorks’ leading consumer-directed benefits with HealthEquity’s HSA platform is highly synergistic and will drive growth while expanding the total addressable market in years to come.

Summary

Health Equity (HQY) has continued its path of accelerating revenue, cash flow, and income growth across all segments of its business in the backdrop of an HSA secular growth market. Its WageWorks acquisition further bolstered this via augmenting its core competencies in the Health Savings Account space while providing access to other revenue verticals in the Consumer Directed-Benefits space. HealthEquity is continuing to post strong growth as it expands the number of accounts, manages more custodial assets, expands gross margins, and more accounts are transitioning into investment vehicles. HealthEquity is uniquely positioned as HSAs are becoming an invaluable option for consumers to contain medical costs and take control of healthcare spending. Best of all, the company’s business model is such that it stands as an intermediary, servicing the secular growth HSA space that’s largely independent of legislative actions, drug pricing, rising insurance costs while not playing any role in the pharmaceutical supply chain from health insurers to end-user pharmacies. The WageWorks acquisition has expanded HealthEquity’s moat while providing additional long-term revenue sources for durable growth.

Noah Kiedrowski
INO.com Contributor

Disclosure: The author holds shares in AAL, AAPL, AMC, AMZN, AXP, CMG, DIA, DIS, FB, GOOGL, GS, HQY, IBM, JPM, KSS, MA, MSFT, QQQ, SBUX, SLB, SPY, TRIP, UPS, USO and X. He may engage in options trading in any of the underlying securities. The author has no business relationship with any companies mentioned in this article. He is not a professional financial advisor or tax professional. This article reflects his own opinions. This article is not intended to be a recommendation to buy or sell any stock or ETF mentioned. Kiedrowski is an individual investor who analyzes investment strategies and disseminates analyses. Kiedrowski encourages all investors to conduct their own research and due diligence prior to investing. Please feel free to comment and provide feedback, the author values all responses. The author is the founder of www.stockoptionsdad.com where options are a bet on where stocks won’t go, not where they will. Where high probability options trading for consistent income and risk mitigation thrives in both bull and bear markets. For more engaging, short duration options based content, visit stockoptionsdad’s YouTube channel.

Posted in INO.com ContributorsTagged Affordable Health Care Act Flexible Savings Account (FSA) Health Plans Health Savings Account (HSA) HealthEquity Inc. (NASDAQ:HQY) High Deductible Health Plans (HDHPs) HSA Assets Medical Coverage Medical Plan Premiums noah kiedrowski Retirement Planning Tax Break traditional IRA WageWorks

Post navigation

Gold & Silver: The King Reins In
U.S. Petroleum Inventories Fall

Search Trader’s Blog

Magnifi Personal

Build a long-term portfolio in minutes. Try Magnifi Personal - Free Trial.

Recent Posts

  • Was Debt-Ceiling Standoff a Concern? Not for These Stocks
  • Is Marvell Technology Inc. (MRVL) a Buy with the Latest AI Projection?
  • Stocks to Keep an Eye on Following Memorial Weekend
  • IonQ, Inc. (IONQ) Hits Amazon… Again: Should Investors Buy Into the Surge?
  • The Changing Landscape of Brick-and-Mortar Stores in Today’s Economy

Market Reports

  • Gold
  • S&P500
  • Dow
  • Nasdaq
  • Crude Oil

Trader Comments

  • Frank on 3 Tech Stocks Turning Negative Sentiment Into Positive Returns
  • Carl M. Welch on Natural Gas: Opportunity of the Year?
  • Frank on Countdown To Catastrophe
  • Conrad Gill on Countdown To Catastrophe
  • Toby Bloom on The Best of the Best in Big Pharma

Categories

  • General
  • INO Cares
  • INO.com Contributors
  • MarketClub Options
  • MarketClub Techniques, Tips & Talk
  • Member Success Stories
  • Trading Videos

Blogroll

  • Add Your Blog Here
  • Cannabis Stock Trades
  • Crude Oil Trader
  • Drift Trader
  • ETF Daily News
  • Learn Options Trading
  • Online Stock Trading Guide
  • Options Trading Mastery
  • Stock Gumshoe
  • Traders Day Trading
  • TradeThatSwing
  • VantagePoint Trading Software
Find INO.com on Facebook Follow MarketClub on Twitter Find MarketClub on YouTube Download on the App Store Get It On Google Play
  • Pulse
  • Markets
  • MarketClub
  • Blog
  • Advertising
  • Help
  • Contact Us
  • Usage Agreement
  • Privacy Policy

© Copyright INO.com, Inc. All Rights Reserved.

INO, a division of TIFIN Group LLC, is affiliated with Magnifi via common ownership. Affiliates of Magnifi will receive cash compensation for referrals of clients who open accounts with Magnifi. Due to this compensation, a conflict of interest exists since INO has an incentive to recommend Magnifi LLC.

Magnifi LLC does not charge advisory fees or transaction fees for non-managed accounts. Clients who elect to have Magnifi LLC manage all or a portion of their account will be charged an advisory fee. Please see Magnifi’s Form ADV for additional information about fees and charges that may apply. Magnifi LLC receives compensation from product sponsors related to recommendations. Other fees and charges may apply.

Do Not Sell My Information

×

It’s not goodbye, it’s hello Magnifi!

You are now leaving a Magnifi Communities’ website and are going to a website that is not operated by Magnifi Communities. This website is operated by Magnifi LLC, an SEC registered investment adviser affiliated with Magnifi Communities.

Magnifi Communities does not endorse this website, its sponsor, or any of the policies, activities, products, or services offered on the site. We are not responsible for the content or availability of linked site.

Take Me To Magnifi